Harlan Waksal's Net Worth
$2.94 Million
Who is Harlan Waksal?
Harlan Waksal has an estimated net worth of $2.94 Million. This is based on reported shares across multiple companies, which include Kadmon Holdings, Inc., Lyra Therapeutics, Inc., and Sevion Therapeutics, Inc..
SEC CIK
Harlan Waksal's CIK is 0001449008
Past Insider Trading and Trends
2010 was Harlan Waksal's most active year for acquiring shares with 17 total transactions. Harlan Waksal's most active month to acquire stocks was the month of October. 2010 was Harlan Waksal's most active year for disposing of shares, totalling 1 transactions. Harlan Waksal's most active month to dispose stocks was the month of April. 2021 saw Harlan Waksal paying a total of $27,577,202.50 for 7,340,748 shares, this is the most they've acquired in one year. In 2021 Harlan Waksal cashed out on 177,945 shares for a total of $1,690,477.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kadmon Holdings, Inc. No price found
President, CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -177.94K |
$9.50 | -$1,690,477.50 |
0
|
Nov 9
| |||
Form 4
| +16.35% | 25K |
$3.56 | $88,977.50 | 177.94K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
| +11.68% | 16K |
$2.93 | $46,811.20 | 152.94K |
Mar 13
| |||
Form 4
| +23.66% | 26.2K |
$3.20 | $83,925.34 | 136.94K |
Sep 28 - Mar 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
| +4.73% | 5K |
$2.27 | $11,332.50 | 110.75K |
Aug 10
| |||
Form 4
| +3.63% | 3.71K |
$2.34 | $8,666.60 | 105.75K |
Aug 8
| |||
Form 4
| +2.00% | 2K |
$6.37 | $12,733.20 | 102.04K |
Nov 16
| |||
Form 4
| +2.04% | 2K |
$6.79 | $13,580.00 | 100.04K |
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyra Therapeutics, Inc. (LYRA) Snapshot price: $4.91
Executive Chair
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +104.98% | 275K |
—
|
—
| 536.97K |
Mar 18
| |||
Form 4
| +10.55% | 25K |
$2.96 | $74,095.00 | 261.97K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 236.97K |
$4.22 | $999,996.52 | 236.97K |
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sevion Therapeutics, Inc. (ELOX) Snapshot price: $0.82125
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
| +44.09% | 858.52K |
$0.26 | $223,214.42 | 2.81M |
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +102.18% | 961.54K |
$0.26 | $249,999.88 | 1.9M |
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| +445.28% | 671.39K |
$0.80 | $540,412.12 | 822.17K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +905.19% | 135.78K |
—
|
—
| 150.78K |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6 - Nov 19
| |||
Form 4
|
∞
| 42.19K |
$0.90 | $13,500.00 | 42.19K |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Perceptive Capital Solutions Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||